InvestorsHub Logo
Followers 5
Posts 557
Boards Moderated 0
Alias Born 06/23/2015

Re: XenaLives post# 100112

Saturday, 04/08/2017 12:01:04 PM

Saturday, April 08, 2017 12:01:04 PM

Post# of 462412
A little more on Harald Hampel

Harald Hampel has, during the past years, received lecture honoraria and/or research grants and/or travel funding and/or participated in scientific advisory boards and/or served as a consultant to diagnostic, biotechnology and pharmaceutical companies involved in the manufacture and marketing of biomarkers and/or diagnostics and/or drugs or medicinal products for cognitive impairment and/or Alzheimer's disease. These companies include Boehringer-Ingelheim, Bristol-Myers Squibb, Elan Corporation, Wyeth, Novartis, Eisai, Pfizer, Schwabe, Sanofi-Aventis, Roche Pharmaceuticals and Diagnostics, GE Healthcare, Astra-Zeneca, Avid, Eli Lilly and Company, Janssen-Cilag, Merz Pharmaceuticals, GlaxoSmithKline-Biologicals, Jung-Diagnostics and Thermo Fisher Scientific Clinical Diagnostics. He is co-inventor in pending patent submissions relating to biological markers and/or diagnostics.

Is that enough expertise for you Amatuer?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News